-
1Academic Journal
المؤلفون: Enrique Aguilar-Ramírez, Valeria Reyes-Pérez, Carlos A. Fajardo-Hernández, Carlos D. Quezada-Suaste, Mario Carreón-Escalante, Verenice Merlin-Lucas, Beatriz Quiroz-García, Vinicio Granados-Soto, José Rivera-Chávez
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Physiology, Pharmacology, Mental Health, Infectious Diseases, Chemical Sciences not elsewhere classified, type ii diabetes, significantly reduced glycemia, putative allosteric modulator, potential acute toxicity, insulin tolerance test, 400 amino acids, duclauxin toward obtaining, duclauxin (< b, 8 (< b, 36b b, produced 38 analogs, one -/ two, 50 sub, 1 b, 1 (< b, vitro <, talaromyces <, h <, docking toward, b series, validated target, extra unsaturation
-
2
المؤلفون: Enrique Aguilar-Ramírez, Valeria Reyes-Pérez, Carlos A. Fajardo-Hernández, Carlos D. Quezada-Suaste, Mario Carreón-Escalante, Verenice Merlin-Lucas, Beatriz Quiroz-García, Vinicio Granados-Soto, José Rivera-Chávez
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Physiology, Pharmacology, Mental Health, Infectious Diseases, Chemical Sciences not elsewhere classified, type ii diabetes, significantly reduced glycemia, putative allosteric modulator, potential acute toxicity, insulin tolerance test, 400 amino acids, duclauxin toward obtaining, duclauxin (< b, 8 (< b, 36b b, produced 38 analogs, one -/ two, 50 sub, 1 b, 1 (< b, vitro <, talaromyces <, h <, docking toward, b series, validated target, extra unsaturation
-
3
المؤلفون: Enrique Aguilar-Ramírez, Valeria Reyes-Pérez, Carlos A. Fajardo-Hernández, Carlos D. Quezada-Suaste, Mario Carreón-Escalante, Verenice Merlin-Lucas, Beatriz Quiroz-García, Vinicio Granados-Soto, José Rivera-Chávez
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Physiology, Pharmacology, Mental Health, Infectious Diseases, Chemical Sciences not elsewhere classified, type ii diabetes, significantly reduced glycemia, putative allosteric modulator, potential acute toxicity, insulin tolerance test, 400 amino acids, duclauxin toward obtaining, duclauxin (< b, 8 (< b, 36b b, produced 38 analogs, one -/ two, 50 sub, 1 b, 1 (< b, vitro <, talaromyces <, h <, docking toward, b series, validated target, extra unsaturation